CCL27 and neoplasm: While investigating the potential of using tumor-infiltrating lymphocytes (TIL) as an adoptive T cell-therapy for high grade serous cancer (HGSC), we identified a regulatory CD56+ ILC population capable of directly regulating T cells [16].